Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Sep 25, 2019

Keywords

ClinConnect Summary

This clinical trial is focused on creating a special database that collects important clinical and biological information from patients being treated with metabolic radiotherapy for certain types of cancer, specifically thyroid cancer, prostate cancer, and neuroendocrine tumors. The goal is to gather this information to help doctors and researchers better understand these treatments and improve patient care in the future.

If you are at least 18 years old and have received treatment in the Nuclear Medicine Department for one of the specified cancers, you may be eligible to participate. You would need to agree to provide a blood sample and give your written consent to take part in the study. Participants can expect to help contribute valuable information that could benefit others in the future, while also receiving careful monitoring during their treatment. It’s important to note that individuals who are pregnant, breastfeeding, or in certain legal circumstances may not be eligible to join the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ at 18 years old,
• • Patient treated in the Nuclear Medicine Department for the treatment by metabolic radiotherapy,
• * Patient treated as part of his treatment for:
• • thyroid cancer,
• • a neuroendocrine tumor or
• • prostate cancer.
• • Patient having accepted the complementary blood sample,
• • Patient having given his informed, written and express consent.
• Exclusion Criteria:
• • Patient not affiliated to a social security scheme,
• • Subject under tutelage, curatorship or safeguard of justice,
• • Patient in an emergency situation
• • Patient whose regular monitoring is a priori impossible for psychological, family, social or geographical reasons,
• • Pregnant and / or breastfeeding woman